FluoroPharma Medical Inc. (FPMI) News Nov 14, 2014, 8:10

New Post Public Reply Private Reply Replies (0) Message Board
Savant
FluoroPharma Medical Inc. (FPMI) News Nov 14, 2014, 8:10 p.m.
MarketWatch News on FPMI
No News currently available for FPMI
Advertisement
Other News on FPMI
Eagle Pharmaceuticals (EGRX) in Focus: Stock Moves 5.6% Higher - Tale of the Tape 8:21 a.m. July 1, 2014 - Zacks.com
10-Q: FLUOROPHARMA MEDICAL, INC. 3:44 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: FLUOROPHARMA MEDICAL, INC. 5:07 a.m. March 25, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: FLUOROPHARMA MEDICAL, INC. 3:28 p.m. Aug. 19, 2013 - Edgar Online - (EDG = 10Q, 10K)
Market Trends Offer Opportunities for FPMI - Analyst Blog 12:01 p.m. May 20, 2013 - Zacks.com
10-Q: FLUOROPHARMA MEDICAL, INC. 4:03 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
FPMI: CardioPET Excellent Image Quality from Phase II - Analyst Blog 4:16 p.m. Feb. 28, 2013 - Zacks.com
BFPET Phase II Trials Commence - Analyst Blog 2:35 p.m. Jan. 3, 2013 - Zacks.com
FPMI - Q2 2012 10-Q Filed - Analyst Blog 4:12 p.m. Aug. 20, 2012 - Zacks.com
BFPET Pre-Phase 2 Study Results Very Encouraging - Analyst Blog 11:37 a.m. July 27, 2012 - Zacks.com
Q1 10-Q, Development On-Track - Analyst Blog 8:16 a.m. May 17, 2012 - Zacks.com
FPMI: CardioPET Phase 2 Trials Initiated - Analyst Blog 7:57 a.m. March 22, 2012 - Zacks.com
FPMI: CardioPET Phase 2 Trials Initiated - Analyst Blog 7:57 a.m. March 22, 2012 - Zacks.com
Initiating Coverage of FluoroPharma Medical - Analyst Blog 11:57 a.m. Jan. 17, 2012 - Zacks.com
Press Releases on FPMI
Journal of Nuclear Cardiology Publication States Preliminary Findings of Phase II Clinical Study Suggest FluoroPharma's CardioPET Has a Promising Role for the Identification of Functionally Significant Coronary Artery Disease 8:55 a.m. Nov. 3, 2014 - Marketwired
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 19, 2014, in Gothenburg, Sweden 7:32 a.m. Oct. 20, 2014 - Marketwired
FluoroPharma Medical Announces Acceptance of Abstract from Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral Presentation at the Annual Congress of the European Association of Nuclear Medicine (EANM), October 18 - 22, 2014, in Gothenburg, Sweden 6:31 a.m. Oct. 6, 2014 - Marketwire
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the 19th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), September 20th in Boston, MA 10:26 a.m. Sept. 22, 2014 - Marketwire
FluoroPharma Medical Announces Acceptance of Abstract From Phase II Clinical Trial of CardioPET (18F FCPHA) for Oral Presentation at the 19th Annual Scientific Session of the American Society of Nuclear Cardiology (ASNC), September 18-21, 2014, in Boston 7:15 a.m. Sept. 2, 2014 - Marketwire
FluoroPharma Announces That Data From Its Phase II Clinical Trial of 18-F FCPHA (CardioPET) Was Presented at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, June 10th in St. Louis, MO 8:48 a.m. June 11, 2014 - Marketwire
FluoroPharma Medical Announces Presentation of Data From Phase II Clinical Trial of 18F FCPHA (CardioPET) at the Society of Nuclear Medicine and Molecular Imaging Annual Meeting, June 7-14, in St. Louis, MO 7:35 a.m. May 29, 2014 - Marketwire
FluoroPharma Medical Chairman & CEO to Present at 15th Annual B. Riley Conference on May 19th at 4:00 pm PDT 6:31 a.m. May 19, 2014 - Marketwire
The World Market for Cardiovascular Diagnostics 5:57 p.m. April 29, 2014 - PR Newswire - PRF
FluoroPharma Appoints Dr. H. William Strauss, Internationally Recognized Expert in the Field of Cardiovascular Nuclear Medicine, to Chair the Scientific Advisory Board 6:28 a.m. April 14, 2014 - Marketwire
FluoroPharma CEO Thijs Spoor to Be Interviewed Live Today on Clear Channel Business Talk Radio 7:16 a.m. April 2, 2014 - Marketwire
FluoroPharma Announces Appointment of Andrew H. Sassine to the Board of Directors 6:34 a.m. March 11, 2014 - Marketwire
Data Presented From FluoroPharma's Phase II Clinical Trial of CardioPET (18F FCPHA) for Assessment of Acute and Chronic Forms of Coronary Artery Disease (CAD) 12:59 p.m. Feb. 6, 2014 - Marketwire
FluoroPharma CEO, Thijs Spoor, to Present Business and Portfolio Updates at the Noble Financial Capital Markets' Tenth Annual Equity Conference January 20, 2014 1:03 p.m. Jan. 15, 2014 - Marketwire
FluoroPharma CEO Thijs Spoor to Provide Business and Portfolio Update at Biotech Showcase 2014 in San Francisco, January 13th-15th 3:06 p.m. Jan. 8, 2014 - Marketwire
FluoroPharma Medical Announces Acceptance of Abstract for Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Winter Meeting 7:31 a.m. Dec. 19, 2013 - Marketwire
FluoroPharma Medical Inc. to Present at the LD Micro Sixth Annual Conference on December 5, 2013 8:40 a.m. Nov. 27, 2013 - Marketwire
FluoroPharma Medical Inc. Is Elected to the Medical Imaging & Technology Alliance (MITA) 9:54 a.m. Nov. 25, 2013 - Marketwire
FluoroPharma Medical, Inc. Names GE Healthcare Veteran, Edward L. Lyons, Jr. to Newly Created Position of Vice President, Marketing 6:46 a.m. Oct. 28, 2013 - Marketwire
FluoroPharma Medical, Inc. Announces Closing of Equity Financing 6:14 a.m. Sept. 19, 2013 - Marketwire
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 232

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 507

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 62

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 223

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 121

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 57

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 233

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Indicators Highlighting Inflation Risks in the US Economy

Updated Category News Views 405

Understanding Inflation Trends and Risks Monitoring inflation trends has become increasingly important in the current economic climate, where the Consumer Price Index (CPI) had previously surged to 9.0%. Now, with inflation levels around 2.7%, many are left observing potential shifts in macroeconomic conditions. As government policies shift, especially with new leadership...

Continue Reading
Cornish Metals Expands Share Capital with New Stock Options

Updated Category News Views 133

Cornish Metals Strengthens Its Financial Position Vancouver-based Cornish Metals Inc. (TSX-V: CUSN, LSE: CUSN) is excited to announce a significant move to bolster its financial stature. The company, known for its focus on mineral exploration and development, specifically its permitted South Crofty tin project, has exercised stock options resulting in the issuance of...

Continue Reading
Jackson Physician Search Celebrates 10 Years of Excellence in Healthcare

Updated Category News Views 149

Jackson Physician Search Celebrated as a Premier Workplace Jackson Physician Search has achieved an impressive milestone by earning No. 2 ranking among medium-sized companies and eighth overall in the esteemed healthcare sector, in the annual Modern Healthcare awards for best places to work. This announcement follows the company's remarkable ten consecutive years on this...

Continue Reading
CAMARA Introduces Revolutionary AI-Driven Network Solutions

Updated Category News Views 128

Revolutionizing AI Applications with CAMARA and MCP CAMARA, an open-source community project, is leading the charge in bridging artificial intelligence (AI) with telecommunication networks via modern APIs. Their innovative approach is outlined in a newly released white paper asserting the capabilities of their Model Context Protocol (MCP) combined with network APIs. The...

Continue Reading
Cohen & Steers Infrastructure Fund: Key Distribution Insights

Updated Category News Views 178

Cohen & Steers Infrastructure Fund Overview Cohen & Steers Infrastructure Fund, Inc. (NASDAQ: UTF) provides valuable investment options focusing on infrastructure. As an influential player in capital assets, the Fund aims to meet the needs of investors looking for sustainable income and growth. Understanding the sources of distribution is essential for shareholders...

Continue Reading